LUND, Sweden, Jan. 25, 2018 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that it has appointed Theradex Oncology, a global contract research organization...